Role of Clostridium perfringens Necrotic Enteritis B-like Toxin in Disease Pathogenesis Original paper

What was reviewed?

This review examined the role of necrotic enteritis B-like (NetB) toxin as a primary virulence factor produced by Clostridium perfringens and its contribution to necrotic enteritis pathogenesis, with emphasis on toxin biology, genetic regulation, host–microbe interactions, and microbiome-associated disease progression. The authors analyzed molecular, microbiological, and pathogenic evidence showing how NetB toxin, encoded on plasmids and regulated by quorum sensing and virulence regulatory systems, enables C. perfringens to transition from a commensal microbiome organism to a dominant pathogen that damages intestinal epithelial cells and disrupts gut integrity, particularly under microbiome-disrupting conditions such as antibiotic withdrawal or co-infection with predisposing organisms.

Who was reviewed?

The review evaluated microbiological, genomic, and experimental studies involving Clostridium perfringens strains isolated from poultry gastrointestinal microbiomes, including both healthy and necrotic enteritis–affected chickens, as well as laboratory models assessing toxin activity and virulence mechanisms. These studies included molecular detection of NetB-positive strains, toxin production assays, and infection models demonstrating that toxin-producing strains expand within the intestinal microbiome and cause epithelial damage, inflammation, and necrotic lesions, confirming the organism’s dual role as both a commensal microbiome member and opportunistic pathogen under favorable ecological conditions.

What were the most important findings?

The most important finding was that NetB toxin functions as a pore-forming virulence factor that directly damages intestinal epithelial cells, allowing Clostridium perfringens to expand within the gut microbiome and induce necrotic enteritis through microbiome disruption and epithelial barrier failure. Major microbial associations showed that NetB-positive strains become dominant in the intestinal microbiome during disease, aided by rapid bacterial growth, toxin-mediated inhibition of competing microbes, and enzymatic degradation of host extracellular matrix components such as collagen and sialic acids. NetB toxin forms transmembrane pores approximately 1.6–1.8 nm in diameter, disrupting cellular ion balance and inducing cell death, which allows bacterial invasion and progressive tissue necrosis. Additional virulence factors, including alpha toxin, perfringolysin O, TpeL toxin, collagenases, and sialidases, further enhance tissue destruction and bacterial proliferation. Importantly, NetB-positive strains were detected more frequently in diseased hosts than healthy microbiomes, although some healthy microbiomes contained NetB-positive strains without active toxin production, indicating that microbiome dysbiosis and environmental triggers regulate toxin expression and disease onset.

What are the greatest implications of this review?

This review demonstrated that microbiome disruption enables NetB-producing Clostridium perfringens to shift from a commensal microbiome member to a dominant toxin-producing pathogen, highlighting NetB toxin as a critical microbiome-linked virulence biomarker and therapeutic target. Clinicians and researchers should recognize that toxin expression, rather than bacterial presence alone, determines pathogenic risk, emphasizing the importance of microbiome stability, toxin detection, and microbial ecology in disease prevention. These findings support microbiome-targeted interventions, including vaccines, probiotics, and toxin-specific diagnostics, as effective strategies to prevent toxin-mediated intestinal disease and preserve microbiome health in vulnerable hosts.